~~<i id='27ED0B21F4'><strike id='27ED0B21F4'><tt id='27ED0B21F4'><pre id='27ED0B21F4'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

knowledge

comprehensive

author：explore 2025-08-12 06:44:08 - browse：1

A European regulatory panel has recommended against approval of a lung cancer drug made by Mirati Therapeutics, the company said Friday.

Mirati said it will appeal the negative opinion of the drug, called Krazati, issued by a committee of the European Medicines Agency that met this week. But for now, the adverse decision is likely to be adopted by European regulators and prevent the company from marketing the pill in Europe.

Krazati works by blocking a specific type of KRAS alteration called G12C, found in approximately 13% of lung tumors.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies
Next article： Texas Medical Board asked to define abortion emergency exception

leisure time

hotspot

leisure time

entertainment

explore

knowledge

Rep.JamesComer(R-Ky.),thechairoftheHouseCommitteeonOversightandAccountability,hastakenaninterestinph

WSS

Lawmakers grill UnitedHealth CEO on Change cyberattack

Gene therapy for Afghan refugees’ infant will be fully covered

Class action alleges UnitedHealth concealed DOJ probe

Has Bernie Sanders reached the limit of his pharma bullying effort?

340B reform proposal comes out of Senate working group

Vyjuvek, a gene therapy for skin wounds, restored vision in one boy

knowledge

comprehensive

leisure time

State Dept. review finds Biden bears some blame for Afghanistan failures

Vyjuvek, a gene therapy for skin wounds, restored vision in one boy

United colonoscopy coverage change 'may cost lives,' doctors say

Can gargling with Listerine treat gonorrhea of the mouth?

Moonlake's readout produced a cash windfall. Risks remain

Warren pushes Witty on UnitedHealth's control over physicians

Hepatitis C has a cure — but many Americans still lack access to it

AltruBio raises $225 million to develop ulcerative colitis drug

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

340B reform proposal comes out of Senate working group

hotspot

Johnson & Johnson sued for allegedly overpaying for workers' drugs

Unique patient identifier: Experts argue the benefits, pitfalls

Padmanee Sharma of MD Anderson at center of lawsuit over credit

HHS's proposed rule does nothing to address the climate crisis

Novel spinal cord stimulator treats paralysis without surgery

Padmanee Sharma of MD Anderson at center of lawsuit over credit

leisure time

entertainment

explore

knowledge